Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

Spinal cord stimulation (SCS) therapies for chronic back and/or leg pain is superior to conventional medical management (CMM) for reduced pain intensity and functional disability, new research ...

For years, options for recovery have been limited, but a newly FDA-cleared external spinal stimulator, ARC-EX Therapy, which ...

Onward's Arc-Ex spinal cord stimulator earned the FDA's de novo classification and U.S. market authorization, according to a Dec. 19 news release.

Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against ...

The spinal cord stimulation technology from Swiss company Onward, called ARC-E-X, helps paralyzed people regain some mobility ...

A pain management expert can also discuss other possibilities, including facet joint injections, other types of injections, ...

The Columbia VA Health Care System reached a significant milestone this month by completing its first spinal cord stimulation ...

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Gregoire Courtine and Jocelyne Bloch, have ...

Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury ...